Your Input: | |||||
VIP | Vasoactive intestinal peptide. (215 aa) | ||||
LOC100220528 | Uncharacterized protein; Belongs to the vasopressin/oxytocin family. (171 aa) | ||||
TRH | Pro-thyrotropin-releasing hormone; Functions as a regulator of the biosynthesis of TSH in the anterior pituitary gland and as a neurotransmitter/ neuromodulator in the central and peripheral nervous systems. (300 aa) | ||||
SYT2 | Synaptotagmin 2. (415 aa) | ||||
CNR2 | Cannabinoid receptor 2; Belongs to the G-protein coupled receptor 1 family. (350 aa) | ||||
DRD2 | Dopamine receptor D2; Belongs to the G-protein coupled receptor 1 family. (473 aa) | ||||
SLC6A1 | Transporter; Belongs to the sodium:neurotransmitter symporter (SNF) (TC 2.A.22) family. (598 aa) | ||||
SYT9 | Uncharacterized protein. (519 aa) | ||||
SLC43A2 | Uncharacterized protein. (564 aa) | ||||
SNCG | Gamma-synuclein; Belongs to the synuclein family. (180 aa) | ||||
LOC100226015 | Uncharacterized protein. (536 aa) | ||||
SLC17A8 | MFS domain-containing protein. (590 aa) | ||||
PINK1 | PTEN induced kinase 1. (515 aa) | ||||
SYT11 | Synaptotagmin 11. (484 aa) | ||||
CLTRN | Collectrin domain-containing protein. (229 aa) | ||||
RAB3GAP1 | RAB3 GTPase activating protein catalytic subunit 1. (987 aa) | ||||
ACE2 | Angiotensin-converting enzyme. (804 aa) | ||||
SYT6 | Synaptotagmin 6. (520 aa) | ||||
SYT4 | Uncharacterized protein. (571 aa) | ||||
CARTPT | CART prepropeptide. (137 aa) | ||||
KCNB1 | Potassium voltage-gated channel subfamily B member 1; Belongs to the potassium channel family. (862 aa) | ||||
SYT12 | Synaptotagmin 12. (472 aa) | ||||
GDNF | Glial cell derived neurotrophic factor. (218 aa) | ||||
DTNBP1 | Dystrobrevin binding protein 1. (351 aa) | ||||
CNR1 | Cannabinoid receptor 1; G-protein coupled receptor for cannabinoids, including endocannabinoids (eCBs), such as N-arachidonoylethanolamide (also called anandamide or AEA) and 2-arachidonoylglycerol (2-AG). Mediates many cannabinoid-induced effects, acting, among others, on food intake, memory loss, gastrointestinal motility, catalepsy, ambulatory activity, anxiety, chronic pain. Signaling typically involves reduction in cyclic AMP (By similarity). In the hypothalamus, may have a dual effect on mitochondrial respiration depending upon the agonist dose and possibly upon the cell type. In [...] (499 aa) | ||||
SYT3 | Uncharacterized protein. (529 aa) | ||||
PSEN1 | Presenilin; Probable subunit of the gamma-secretase complex, an endoprotease complex that catalyzes the intramembrane cleavage of integral membrane proteins such as Notch receptors. Belongs to the peptidase A22A family. (467 aa) | ||||
SYT13 | Synaptotagmin 13. (431 aa) | ||||
SNCA | Alpha-synuclein; Belongs to the synuclein family. (201 aa) | ||||
SYT7 | Synaptotagmin 7. (684 aa) | ||||
GRM2 | Glutamate metabotropic receptor 2. (869 aa) | ||||
SYT1 | Synaptotagmin I. (425 aa) | ||||
SLC7A5 | Solute carrier family 7 member 5. (522 aa) | ||||
ARL6IP5 | PRA1 family protein. (188 aa) | ||||
SYT8 | Synaptotagmin 8. (393 aa) | ||||
SYT17 | Synaptotagmin 17. (474 aa) | ||||
DRD3 | Dopamine receptor D3; Belongs to the G-protein coupled receptor 1 family. (493 aa) | ||||
SYT10 | Synaptotagmin 10. (522 aa) |